<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genet</journal-id><journal-title>BMC Genetics</journal-title><issn pub-type="epub">1471-2156</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2156-8-17</article-id><article-id pub-id-type="pmid">17477860</article-id><article-id pub-id-type="doi">10.1186/1471-2156-8-17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Mutation screen and association studies in the Diacylglycerol O-acyltransferase homolog 2 gene (<italic>DGAT2</italic>), a positional candidate gene for early onset obesity on chromosome 11q13</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Friedel</surname><given-names>Susann</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Susann.Friedel@uni-due.de</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Reichwald</surname><given-names>Kathrin</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I8">8</xref><email>KReichwald@fli-leibnitz.de</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Scherag</surname><given-names>Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Scherag@staff.uni-marburg.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Brumm</surname><given-names>Harald</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>Harald.Brumm@charite.de</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Wermter</surname><given-names>Anne-Kathrin</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>Wermtera@med.uni-marburg.de</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Fries</surname><given-names>Hans-Rudolf</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>Ruedi.Fries@tierzucht.tum.de</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Koberwitz</surname><given-names>Kerstin</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>Koberwitz@gsf.de</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Wabitsch</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>Martin.Wabitsch@uniklinik-ulm.de</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Meitinger</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>Meitinger@gsf.de</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Platzer</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="I8">8</xref><email>Mplatzer@fli-leibnitz.de</email></contrib><contrib id="A11" contrib-type="author"><name><surname>Biebermann</surname><given-names>Heike</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>Heike.Biebermann@charite.de</email></contrib><contrib id="A12" contrib-type="author"><name><surname>Hinney</surname><given-names>Anke</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Anke.Hinney@uni-due.de</email></contrib><contrib id="A13" corresp="yes" contrib-type="author"><name><surname>Hebebrand</surname><given-names>Johannes</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Johannes.Hebebrand@uni-due.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Virchowstr. 174, 45147 Essen, Germany</aff><aff id="I2"><label>2</label>Institute of Medical Biometry and Epidemiology, Philipps-University, Bunsenstr. 3, 35037 Marburg, Germany</aff><aff id="I3"><label>3</label>Department of Pediatric Endocrinology, Charite Children's Hospital, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany</aff><aff id="I4"><label>4</label>Clinical Research Group, Department of Child and Adolescent Psychiatry, Philipps-University, Schuetzenstr. 49, 35037 Marburg, Germany</aff><aff id="I5"><label>5</label>Chair of Animal Breeding, Technical University Munich, Hochfeldweg 1; 85350 Freising-Weihenstephan, Germany</aff><aff id="I6"><label>6</label>GSF National Research Center for Environment and Health, Ingolstaedter Landstr. 1, 85764 Neuherberg, Germany</aff><aff id="I7"><label>7</label>Department of Pediatrics and Adolescent Medicine, University of Ulm, Eythstra&#x000df;e 24, 89081 Ulm, Germany</aff><aff id="I8"><label>8</label>Genome Analysis, Leibniz Institute for Age Research &#x02013; Fritz Lipmann Institute, Beutenbergstrasse 11, 07745 Jena, Germany</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>3</day><month>5</month><year>2007</year></pub-date><volume>8</volume><fpage>17</fpage><lpage>17</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2156/8/17"/><history><date date-type="received"><day>23</day><month>10</month><year>2006</year></date><date date-type="accepted"><day>3</day><month>5</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Friedel et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Friedel et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Friedel Susann Susann.Friedel@uni-due.de </dc:author><dc:title> Mutation screen and association studies in the Diacylglycerol O-acyltransferase homolog 2 gene (DGAT2), a positional candidate gene for early onset obesity on chromosome 11q13 </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Genetics 8(1): 17-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2156(2007)8:1&#x0003c;17&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2156</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p><italic>DGAT2 </italic>is a promising candidate gene for obesity because of its function as a key enzyme in fat metabolism and because of its localization on chromosome 11q13, a linkage region for extreme early onset obesity detected in our sample.</p><p>We performed a mutation screen in 93 extremely obese children and adolescents and 94 healthy underweight controls. Association studies were performed in samples of up to 361 extremely obese children and adolescents and 445 healthy underweight and normal weight controls. Additionally, we tested for linkage and performed family based association studies at four common variants in the 165 families of our initial genome scan.</p></sec><sec><title>Results</title><p>The mutation screen revealed 15 DNA variants, four of which were coding non-synonymous exchanges: p.Val82Ala, p.Arg297Gln, p.Gly318Ser and p.Leu385Val. Ten variants were synonymous: c.-9447A &#x0003e; G, c.-584C &#x0003e; G, c.-140C &#x0003e; T, c.-30C &#x0003e; T, IVS2-3C &#x0003e; G, c.812A &#x0003e; G, c.920T &#x0003e; C, IVS7+23C &#x0003e; T, IVS7+73C &#x0003e; T and *22C &#x0003e; T. Additionally, the small biallelic trinucleotide repeat rs3841596 was identified. None of the case control and family based association studies showed an association of investigated variants or haplotypes in the genomic region of <italic>DGAT2</italic>.</p></sec><sec><title>Conclusion</title><p>In conclusion, our results do not support the hypothesis of an important role of common genetic variation in <italic>DGAT2 </italic>for the development of obesity in our sample. Anyhow, if there is an influence of genetic variation in <italic>DGAT2 </italic>on body weight regulation, it might either be conferred by the less common variants (MAF &#x0003c; 0.1) or the detected, rare non-synonymous variants.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Obesity has become a major public health problem in industrialized countries and its prevalence is still increasing worldwide [<xref ref-type="bibr" rid="B1">1</xref>]. Estimates from twin studies attribute up to 80% of human body weight variation to genetic factors [<xref ref-type="bibr" rid="B2">2</xref>] and positional candidate gene analyses in linkage peak regions identified in genome wide scans for obesity have been suggested as a means to detect obesity associated genes [i.e. [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B7">7</xref>]]. Examples for positional candidate gene association findings pertain to (a) <italic>SLC6A14 </italic>on chromosome (chr.) Xq24 [<xref ref-type="bibr" rid="B3">3</xref>] which was confirmed by Durand et al. [<xref ref-type="bibr" rid="B4">4</xref>] and (b) <italic>GAD2 </italic>on chr. 10p12 [<xref ref-type="bibr" rid="B5">5</xref>] which was confirmed by the same group [<xref ref-type="bibr" rid="B6">6</xref>]. In contrast, Swarbrick et al. [<xref ref-type="bibr" rid="B7">7</xref>] found no evidence for a relationship between the three <italic>GAD2 </italic>SNPs and obesity in a sample comprising 2,359 individuals.</p><p>A genome wide scan for obesity based on 89 German families, comprising extremely obese children and adolescents and both of their parents and at least one obese sib, identified nine regions with maximum likelihood binomial logarithm of the odd (MLB LOD) scores &#x0003e; 0.7; in an independent confirmation sample of 76 obesity families MLB LOD scores of 0.68 and 0.71 were observed for chromosomes 10p11.23 and 11q13, respectively [<xref ref-type="bibr" rid="B8">8</xref>].</p><p>The hypothesis of a susceptibility gene for obesity and related phenotypes on chromosome 11q13 was additionally supported by independent linkage studies for BMI and obesity related phenotypes [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. Further support was obtained from chromosomal regions homologous to human chromosome 11q13 in rodents in which quantitative trait loci (QTL) for obesity related phenotypes such as leptin level [<xref ref-type="bibr" rid="B13">13</xref>] and BMI [<xref ref-type="bibr" rid="B14">14</xref>] were identified. Taken together, there is evidence for a candidate gene for obesity in this chromosomal region.</p><p>In earlier studies, we investigated different promising candidate genes on chr.11q, but none of them contributed to the linkage peak [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. Diacylglycerol-O-acyltransferase homolog 2 (<italic>DGAT2</italic>), another potential candidate gene, is also located on chr. 11q13. DGAT2 is a key enzyme in fat metabolism [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. It is responsible for the synthesis of triglycerides and catalyzes the reaction that joins diacylglycerol covalently to long chain fatty acyl-CoAs. It was hypothesized that leptin regulates adipocyte size by altering expression patterns of Diacylglycerol O-acyltransferase 1 (DGAT1) and its functional homolog DGAT2 via the CNS to determine the levels of triglyceride synthesis [<xref ref-type="bibr" rid="B20">20</xref>]. The deduced 387-amino acid human DGAT2 protein contains at least one transmembrane domain, three potential N-linked glycosylation sites, six potential phosphorylation sites, and a putative glycerol phospholipid domain found in acyltransferases [<xref ref-type="bibr" rid="B18">18</xref>]. Although functionally related, <italic>DGAT2 </italic>shares no sequence homology with the members of the <italic>DGAT1 </italic>family. The gene was identified via homology search with fungal DGAT subsequent to the finding that <italic>Dgat1 </italic>knockout mice (<italic>Dgat1</italic><sup>-/-</sup>) were viable and still able to synthesize triglycerides [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B21">21</xref>].</p><p><italic>Dgat2 </italic>knockout mice (<italic>Dgat2</italic><sup>-/-</sup>) are lipopenic, their total carcass triglyceride content was reduced by 93% [<xref ref-type="bibr" rid="B22">22</xref>]. In contrast to <italic>Dgat1</italic><sup>-/- </sup>mice, where <italic>Dgat2 </italic>is able to compensate the role of Dgat1 in triglyceride synthesis, <italic>Dgat1 </italic>was unable to compensate for the absence of Dgat2 in <italic>Dgat2</italic><sup>-/- </sup>mice. <italic>Dgat2</italic><sup>-/- </sup>mice die in the early postnatal period, apparently from abnormalities in energy homeostasis and from impaired permeability barrier function in the skin. The results indicate that Dgat2 is the major enzyme of triglyceride synthesis in mice [<xref ref-type="bibr" rid="B22">22</xref>].</p><p>Based on both positional as well as on functional arguments, we hypothesized that genetic variations in <italic>DGAT2 </italic>might alter triglyceride synthesizing activity of the protein in humans. Genetic variations leading to a gain of function of DGAT2 may thus be associated with obesity, whereas variations entailing a reduced function could be relevant in underweight.</p></sec><sec><title>Results</title><sec><title>Gene structure</title><p>To include all potentially relevant exons of <italic>DGAT2</italic>, its structure was analyzed both <italic>in silico </italic>and experimentally. Visual inspection of ESTs assembled to the <italic>DGAT2 </italic>locus in the UCSC genome browser identified two ESTs (BF979495, BF979677) which seemed to harbour alternative/additional exons. The sequences of both ESTs overlap by 200 bp and form a transcript of 1,238 bp. Alignment of this mRNA to genomic DNA revealed the presence of an alternative first noncoding exon of human <italic>DGAT2</italic>, while exons2&#x02013;8 are as defined by AB048286 (suppl. table <xref ref-type="table" rid="T1">1</xref>). Sequencing of EST BF979677 revealed the presence of an alternative internal exon which is located between exon1 and exon2 as defined in AB048286. Furthermore, by RT-PCR in human adipocyte mRNA, a transcript was identified that comprised 7exons in which exon1 and exons3&#x02013;8 are as defined by AB048286 while exon 2 is missing. In sum, three alternatively spliced transcripts of the human <italic>DGAT2 </italic>gene were identified. Including the two previously reported mRNAs (AB048286, ENST00000228027) there are at least five different mRNAs transcribed from this locus [see additional file <xref ref-type="supplementary-material" rid="S1">1</xref>].</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Summary of DGAT2 variants detected in the coding region, the predicted promoter region and a 5'non-coding exon: 15 (14 novel) identified and 2 previously described (rs1017713 and rs3060), minor allele frequency among all successfully genotyped individuals and results of the case control association studies with cases (extremely obese children and adolescents) and controls (normal- or underweight healthy individuals)</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" colspan="2"><bold>variant</bold></td><td align="center"><bold>region</bold></td><td align="center"><bold>Study group<sup>1</sup></bold></td><td align="center" colspan="2"><bold>minor allele frequency n (%)</bold></td><td align="center"><bold>p-value<sup>2</sup></bold></td></tr><tr><td></td><td></td><td></td><td></td><td colspan="2"><hr></hr></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td align="center"><bold>cases</bold></td><td align="center"><bold>controls</bold></td><td></td></tr></thead><tbody><tr><td align="center">g.-9447 A &#x0003e; G</td><td></td><td align="center">exon 01</td><td align="center">2</td><td align="center">29 (8.06)</td><td align="center">33 (8.82)</td><td align="center">0.79</td></tr><tr><td align="center">c.-584C &#x0003e; G</td><td></td><td align="center">promoter</td><td align="center">1</td><td align="center">0 (0)</td><td align="center">1 (0.53)</td><td align="center">nd.</td></tr><tr><td align="center">c.-140C &#x0003e; T</td><td></td><td align="center">5'UTR/exon 1</td><td align="center">3</td><td align="center">2 (0.28)</td><td align="center">9 (1.01)</td><td align="center">0.13</td></tr><tr><td align="center">c.-30C &#x0003e; T</td><td></td><td align="center">5'UTR/exon 1</td><td align="center">1</td><td align="center">0 (0)</td><td align="center">2 (1.06)</td><td align="center">nd.</td></tr><tr><td align="center">c.475T &#x0003e; C</td><td align="center">p.Val82Ala</td><td align="center">exon 2</td><td align="center">1</td><td align="center">1 (0.54)</td><td align="center">0 (0)</td><td align="center">nd.</td></tr><tr><td align="center">g.IVS1+212T &#x0003e; C</td><td align="center">rs1017713</td><td align="center">exon 2</td><td align="center">2</td><td align="center">25 (7.65)</td><td align="center">26 (7.06)</td><td align="center">0.77</td></tr><tr><td align="center">g.IVS2-3C &#x0003e; G</td><td></td><td align="center">intron 2</td><td align="center">1</td><td align="center">0 (0)</td><td align="center">1 (0.53)</td><td align="center">nd.</td></tr><tr><td align="center">c.812A &#x0003e; G</td><td align="center">p.Thr194Thr</td><td align="center">exon 5</td><td align="center">1</td><td align="center">1 (0.54)</td><td align="center">0 (0)</td><td align="center">nd.</td></tr><tr><td align="center">c.920T &#x0003e; C</td><td align="center">p.Ser230Ser</td><td align="center">exon 6</td><td align="center">1</td><td align="center">1 (0.54)</td><td align="center">0 (0)</td><td align="center">nd.</td></tr><tr><td align="center">c.1020G &#x0003e; A</td><td align="center">p.Arg297Gln</td><td align="center">exon 7</td><td align="center">1</td><td align="center">0 (0)</td><td align="center">2 (1.06)</td><td align="center">nd.</td></tr><tr><td align="center">c.1492G &#x0003e; A</td><td align="center">p.Gly318Ser</td><td align="center">exon 7</td><td align="center">1</td><td align="center">0 (0)</td><td align="center">2 (1.06)</td><td align="center">nd.</td></tr><tr><td align="center">g.IVS7+23C &#x0003e; T</td><td></td><td align="center">intron 7</td><td align="center">1</td><td align="center">1 (0.54)</td><td align="center">0 (0)</td><td align="center">nd.</td></tr><tr><td align="center">g.IVS7+73C &#x0003e; T</td><td></td><td align="center">intron 7</td><td align="center">1</td><td align="center">2 (1.08)</td><td align="center">0 (0)</td><td align="center">nd.</td></tr><tr><td align="center">g.IVS7+164(TAG)2&#x02013;3</td><td align="center">rs3841596</td><td align="center">intron 7</td><td align="center">2</td><td align="center">24 (6.67)</td><td align="center">28 (7.61)</td><td align="center">0.67</td></tr><tr><td align="center">c.1383C &#x0003e; G</td><td align="center">p.Leu385Val</td><td align="center">exon 8</td><td align="center">1</td><td align="center">0 (0)</td><td align="center">1 (0.53)</td><td align="center">nd.</td></tr><tr><td align="center">g.*19T &#x0003e; C</td><td align="center">rs3060</td><td align="center">3'UTR/exon 8</td><td align="center">2</td><td align="center">27 (7.50)</td><td align="center">27 (7.76)</td><td align="center">1</td></tr><tr><td align="center">g.*22C &#x0003e; T</td><td></td><td align="center">3'UTR/exon 8</td><td align="center">1</td><td align="center">1 (0.54)</td><td align="center">0 (0)</td><td align="center">nd.</td></tr></tbody></table><table-wrap-foot><p>Hardy Weinberg equilibrium was fulfilled (all exact <italic>p </italic>&#x0003e; &#x0003e; 0.20). <sup>1</sup>for descriptions of study groups see Methods; <sup>2</sup>Fisher's exact test, two-sided.</p></table-wrap-foot></table-wrap></sec><sec><title>Mutation screen</title><p>Screening was performed in the coding region, the predicted promoter region and in the identified non-coding 5' exon. The mutation screen in ten fragments comprised 3,079 bps and revealed 15 (14 novel) DNA variants, four of which are coding non-synonymous exchanges: p.Val82Ala, p.Arg297Gln, p.Gly318Ser and p.Leu385Val whereas ten variants are synonymous c.-9447A &#x0003e; G, c.-584C &#x0003e; G, c.-140C &#x0003e; T, c.-30C &#x0003e; T, IVS2&#x02013;3C &#x0003e; G, c.812A &#x0003e; G, c.920T &#x0003e; C, IVS7+23C &#x0003e; T, IVS7+73C &#x0003e; T and *22C &#x0003e; T (see also table <xref ref-type="table" rid="T1">1</xref>). Additionally, a small known biallelic trinucleotide repeat (IVS7+164(TAG)2&#x02013;3 = rs3841596) located in intron 7 was identified.</p></sec><sec><title>Case control association studies</title><p>Minor allele frequencies (MAF) of the variants were estimated in sample 1. Most of the variants were rare and it was thus decided to genotype only the more frequent variations rs3841596, rs1017713 and rs3060 in sample 2. Variant -140C &#x0003e; T, located 5' to the translation start, was genotyped in sample 3 which includes sample 2 but is larger and therefore has an improved power (see table <xref ref-type="table" rid="T1">1</xref>). Given the sample sizes, the study had a statistical power of more than 80% to detect allelic differences between the respective case and control groups of e.g. 0.17 and 0.1 in MAFs. Genotype distribution in all study samples did not differ from Hardy-Weinberg equilibrium. No significant differences in genotype or allele distributions were found in samples 2 and 3, all nominal p-values were &#x0003e;&#x0003e; 0.05 (see table <xref ref-type="table" rid="T1">1</xref>).</p></sec><sec><title>Family based association studies</title><p>To investigate the contribution of <italic>DGAT2 </italic>polymorphisms to the linkage peak on chromosome 11q13 [<xref ref-type="bibr" rid="B8">8</xref>] SNPs -9447A &#x0003e; G and -140C &#x0003e; T, as well as two additional known variants (rs1017713 (IVS1+212T &#x0003e; C) and rs3060 (*19T &#x0003e; C)) were genotyped in the families contributing to the genome scan peak (sample 4). Neither single marker family based association analyses (PDT) in all 165 families nor in the 48 families contributing to the linkage peak on 11q13, revealed significant evidence for allelic associations (all p-values &#x0003e; &#x0003e; 0.05). Consistent with this finding, subsequent haplotype analyses using FAMHAP did not indicate an associated haplotype (best nominal p-value 0.5 with the zhaomax allcombi option).</p></sec></sec><sec><title>Discussion</title><p>The linkage scan in 89 families revealed the highest LOD at D11S1313. Subsequent fine-mapping in 76 independent families revealed a combined peak region at position 67.8 &#x02013; 69.1 Mb (approximately 68.55 - 68.01 cM, UCSC, hg16) between D11S1337 and D11S4095 [<xref ref-type="bibr" rid="B8">8</xref>, <italic>unpublished data</italic>]. <italic>DGAT2 </italic>is located at 75 Mb and thus close to this peak region. In light of the small sample size, which leads to considerable stochastic variation in the location estimate of linkage peaks [<xref ref-type="bibr" rid="B23">23</xref>] and combined with its important role in fat metabolism <italic>DGAT2 </italic>is a very plausible positional and functional candidate gene for obesity in our sample.</p><p>A mutation screen in the coding region of the gene, the predicted promoter sequence and a 5' non-coding exon (altogether 3,079 bp) revealed 15 genetic variants, 14 of which were novel. Twelve of the variants were rare (MAF = 1%) and would thus have a too low statistical power to allow for a comparison in a case control association analysis. Nonetheless, these rare variants might have an impact on the phenotype. Four coding non-synonymous variants were detected: p.Val82Ala occurred once in an extremely obese male, whereas p.Arg297Gln, p.Gly318Ser and p.Leu385Val were detected in underweight controls. [<xref ref-type="bibr" rid="B1">1</xref>] The conservative amino acid (aa) exchange p.Val82Ala is located in a predicted transmembrane domain of the DGAT2 protein [<xref ref-type="bibr" rid="B18">18</xref>]. This position is situated within an area highly conserved among the selected species with Val82 being unchanged for more than 1 billion years of evolution. While this non-synonymous variant seemingly does not affect the predicted transmembrane domain (aa 73 to aa 95), altered function may be the consequence as already postulated for other genes [<xref ref-type="bibr" rid="B24">24</xref>]. Moreover, for the very same aa substitution positioned within a transmembrane domain (TM) an inactivating variant in TM2 of the monocarboxylate transporter 8 [<xref ref-type="bibr" rid="B25">25</xref>] as well as an activating variant in TM1 of the lutropin receptor [<xref ref-type="bibr" rid="B26">26</xref>] had been described. Therefore although Val82Ala is a conservative exchange it has been shown that a Valin to Alanin substitution is able to materially affect membrane protein functions in both an activating as well as in an inactivating manner. Hence, assuming that a gain of function might well lead to obesity, it is reasonable to consider the Valin to Alanin substitution in DGAT2 as a potential cause for the patient's remarkably increased BMI (see table <xref ref-type="table" rid="T2">2</xref>). [<xref ref-type="bibr" rid="B2">2</xref>] Arg297Gln is a non conservative amino acid exchange. In contrast to arginine, glutamine has an amide-side group that is able to form hydrogen bonds, which might influence protein structure. However, positioned in a region of little evolutionary conservation characterised by a difference in amino acid sequence length between mammals and plants and a non-conservative amino acid exchange between these kingdoms (basic polar arginine in mammals vs. neutral unpolar methionine in plants) an exchange of the wt arginine vs. also polar but neutral glutamine does not suggest a functional consequence of this substitution. [<xref ref-type="bibr" rid="B3">3</xref>] The substitution of glycine to serine at position 318 is also non-conservative. During evolution persisted at this position a neutral unpolar amino acid; therefore an exchange by polar serine may be functionally relevant. However, several amino acids flanking position 318 show little conservation; therefore the patient's remarkably low BMI as consequence of this amino acid substitution seems rather speculative. [<xref ref-type="bibr" rid="B4">4</xref>] The exchange of leucine to valine at position 385 is conservative. The non reactive aliphatic side chains of leucine and valine that are important for hydrophobic bonds within the protein are not affected. Functional studies of these variants in DGAT2 have to be performed to clarify the effect of the detected variants on body weight regulation.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Phenotypic characteristics (gender, age, BMI, BMI-SDS) of heterozygous carriers of infrequent variants detected in the genomic region of <italic>DGAT2</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Mutation</bold></td><td align="center"><bold>Gender</bold></td><td align="center"><bold>Age [years]</bold></td><td align="center"><bold>BMI [kg/m<sup>2</sup>]</bold></td><td align="center"><bold>BMI-SDS*</bold></td></tr></thead><tbody><tr><td align="center">p.V82A</td><td align="center">male</td><td align="center">12</td><td align="center">29.30</td><td align="center">3.6</td></tr><tr><td align="center">p.R297Q</td><td align="center">female</td><td align="center">26</td><td align="center">16.9</td><td align="center">-1.3</td></tr><tr><td></td><td align="center">female</td><td align="center">23</td><td align="center">17.0</td><td align="center">-1.6</td></tr><tr><td align="center">p.G318S</td><td align="center">male</td><td align="center">25</td><td align="center">19.6</td><td align="center">-1.2</td></tr><tr><td></td><td align="center">male</td><td align="center">20</td><td align="center">17.9</td><td align="center">-1.9</td></tr><tr><td align="center">p.L385V</td><td align="center">male</td><td align="center">23</td><td align="center">20.4</td><td align="center">-0.9</td></tr><tr><td align="center">c.812A &#x0003e; G (T194T)</td><td align="center">female</td><td align="center">12</td><td align="center">31.4</td><td align="center">4.6</td></tr><tr><td align="center">c.920T &#x0003e; C (S230S)</td><td align="center">male</td><td align="center">13</td><td align="center">31.5</td><td align="center">3.7</td></tr><tr><td align="center">-584C &#x0003e; G</td><td align="center">female</td><td align="center">34</td><td align="center">18.4</td><td align="center">-1.3</td></tr><tr><td align="center">-30C &#x0003e; T</td><td align="center">male</td><td align="center">24</td><td align="center">19.6</td><td align="center">-1.4</td></tr><tr><td align="center">IVS2&#x02013;3C &#x0003e; G</td><td align="center">male</td><td align="center">27</td><td align="center">19.5</td><td align="center">-1.5</td></tr><tr><td align="center">IVS7+23C &#x0003e; T</td><td align="center">female</td><td align="center">14</td><td align="center">35.9</td><td align="center">5.4</td></tr><tr><td></td><td align="center">female</td><td align="center">16</td><td align="center">33.8</td><td align="center">5.2</td></tr><tr><td align="center">IVS7+73C &#x0003e; T</td><td align="center">male</td><td align="center">12</td><td align="center">29.3</td><td align="center">3.3</td></tr><tr><td align="center">*22C &#x0003e; T</td><td align="center">male</td><td align="center">21</td><td align="center">33.8</td><td align="center">4.7</td></tr></tbody></table><table-wrap-foot><p>All individuals are heterozygous carries of these variants. * Estimates based on Hebebrand et al., 1996 (53)</p></table-wrap-foot></table-wrap><p>There is no indication that the rare synonymous variants might have an effect on body weight regulation. Variant c.-584C &#x0003e; G in the putative promoter region is located in a potential binding site for the transcription factor ARP-1 (COUP-TF II), which might participate in regulation of lipid metabolism and cholesterol synthesis [<xref ref-type="bibr" rid="B27">27</xref>] and is assumed to negatively influence PPAR&#x003b1; gene transcription [<xref ref-type="bibr" rid="B28">28</xref>]. Two variants were detected in untranslated regions (-30C &#x0003e; T in the 5'UTR and *22C &#x0003e; T in the 3'UTR). These variants may influence mRNA stability, but as they are rare, we assumed that they have no major effect on common obesity under a "common disease common variant"-perspective given that the estimated MAF of each variant was 1/186 = 0.54% (95% confidence interval 0.014%...2.96%). The intronic variants IVS2&#x02013;3C &#x0003e; G, IVS7+23C &#x0003e; T and IVS7+73C &#x0003e; T are also rare and neither affect any consensus splice site nor do they introduce cryptic splice sites. None of the case control and family based association studies showed an association of investigated variants or haplotypes in the genomic region of <italic>DGAT2</italic>.</p><p>Starting off with a mutation screen of the coding sequence and the 5'flanking region we were investigating both case control samples and independent samples with families contributing to a linkage peak. However, due to insufficient statistical power to explore the less common variants (MAF &#x0003c; 0.1), our study design only allows evaluation of common variants.</p><p>In conclusion, our results do not support the hypothesis of an important role of common genetic variation in <italic>DGAT2 </italic>for the development of obesity in our sample. One may thus speculate that if there is an influence of genetic variation in <italic>DGAT2 </italic>on body weight regulation, it might either be the less common synonymous or non-coding variants that play an important role.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study subjects</title><p>The ascertainment strategy for the extremely obese and underweight study groups was previously described in detail [<xref ref-type="bibr" rid="B29">29</xref>]. Briefly, extremely obese German index patients were ascertained at German hospitals specialized in inpatient treatment of extreme obesity in children and adolescents. All index patients had an age- and gender-specific BMI &#x02265;90<sup>th </sup>percentile as previously determined in a representative German population sample [<xref ref-type="bibr" rid="B30">30</xref>]. The BMIs of the underweight students were below the 15th percentile whereas normal weight controls had BMIs between the 40<sup>th </sup>and the 60<sup>th </sup>age- and gender-specific percentile. Mean BMI and age and the respective standard deviations are provided below. Written informed consent was given by all participants and, in the case of minors, their parents. This study was approved by the Ethics Committee of the University of Marburg.</p><p>The coding exons of <italic>DGAT2</italic>, the predicted promoter region and an additionall non-coding 5' exon were screened in a 'screening sample' (sample 1) comprising 93 extremely obese children and adolescent cases (48.4 % females, mean BMI 34.4 &#x000b1; 5.0 kg/m<sup>2</sup>; mean age 14.1 &#x000b1; 2.0 yrs) and 94 healthy underweight controls (36.2 % females, mean BMI 18.5 &#x000b1; 1.2 kg/m<sup>2</sup>; mean age 25.5 &#x000b1; 4.0 yrs). Identified sequence variants were genotyped in sample 2, comprising both the initial groups (sample 1) and additional 87 cases (51.7 % females, mean BMI 36.9 &#x000b1; 7.0 kg/m<sup>2</sup>; mean age 14.6 &#x000b1; 2.8 yrs) as well as 93 healthy underweight controls (52.7 % females, mean BMI 18.3 &#x000b1; 1.0 kg/m<sup>2</sup>; mean age 25.7 &#x000b1; 3.8 yrs). Finally, in order to increase the power to detect association for one variant (-140C &#x0003e; T), sample 2 was further extended (sample 3). Sample 3 comprised a total of 361 extremely obese cases (53.2 % females, mean BMI 34.7 &#x000b1; 6.3 kg/m<sup>2</sup>; mean age 14.4 &#x000b1; 2.6 yrs) and a total of 445 control subjects comprising 278 underweight students (50.7 % females, mean BMI 18.2 &#x000b1; 1.1 kg/m<sup>2</sup>; mean age 25.0 &#x000b1; 3.7 yrs) and 167 normal weight controls (60.5 % females, mean BMI 21.8 &#x000b1; 1.1 kg/m<sup>2</sup>; mean age 24.6 &#x000b1; 2.4 yrs).</p><p>To investigate the potential genetic effects of variants in <italic>DGAT2 </italic>on body weight regulation; SNPs rs1017713, rs3060, -9447A &#x0003e; G and -140C &#x0003e; T were genotyped in a family based association analysis, the respective markers were also genotyped in the 165 genome scan families (sample 4) described previously [<xref ref-type="bibr" rid="B8">8</xref>] to test for linkage. Sample 4 is independent of samples 1&#x02013;3. The aim of our study was the investigation of associations of <italic>common DGAT2 </italic>variants with extreme early-onset obesity.</p></sec><sec><title>Promoter prediction and evaluation of gene structure</title><p>Promoter sequence was predicted by PromoterInspector, Mammalian Promoter Prediction Software from Genomatix, [<xref ref-type="bibr" rid="B31">31</xref>]. Analyses were based on human genome assemblies hg15 and hg16 [<xref ref-type="bibr" rid="B32">32</xref>] and the corresponding ENSEMBL genome browser [<xref ref-type="bibr" rid="B33">33</xref>]. cDNA clone sequences of Unigene cluster Hs.334305 representative for the human <italic>DGAT2 </italic>gene were downloaded from NCBI [<xref ref-type="bibr" rid="B34">34</xref>] and assembled using GAP4 [<xref ref-type="bibr" rid="B35">35</xref>]. <italic>DGAT2 </italic>transcripts were aligned to human genomic sequence using Sim4 [<xref ref-type="bibr" rid="B36">36</xref>]. Two known human mRNAs mapped to the <italic>DGAT2 </italic>locus in genome assemblies hg15 and hg16. One of these, AB048286 (2,439 bp) formed the basis for RefSeq entry NM_032564, the annotation status of which was provisional. The second mRNA AL834287 (2,347 bp) was 92 bp shorter at its 5'end than AB048286. Nonetheless, both transcripts harbour 8 exons; and as defined by AB048286, the human <italic>DGAT2 </italic>at chr. 11q13.5 covers 32,766 bp with a coding region (CDS) of 1167 bp extending from exon1 to exon8. In the corresponding Ensembl genome browser [<xref ref-type="bibr" rid="B33">33</xref>] there were also two transcripts assigned to the <italic>DGAT2 </italic>locus (ENST00000289503, 1,545 bp; ENST00000228027, 2,238 bp). The former entry harboured 8 exons as found in AB048286 while the latter contained only 7 exons, i.e. exon5 was missing which indicated the presence of at least one alternatively spliced <italic>DGAT2 </italic>transcript.</p></sec><sec><title>Sequencing</title><p>Human cDNA clone BF979958 was obtained from RZPD [<xref ref-type="bibr" rid="B37">37</xref>] and cultured by standard methods [<xref ref-type="bibr" rid="B38">38</xref>]. Sequencing was performed using vector primers and BigDye Terminator Cycle Sequencing v2.0 kit (Applied Biosystems, Weiterstadt, Germany). Sequencing reactions were electrophoresed on ABI 3700 automated sequencers. Base calling was performed using phred [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. Sequence assembly was done using phrap [<xref ref-type="bibr" rid="B41">41</xref>]. Trace files were inspected visually in GAP4. RT-PCR: Primers located in exons 1 and 8 of <italic>DGAT2 </italic>as defined by reference sequence NM_032564 were used in a nested PCR approach (PCR I: 1F [ACCCTCATAGCCGCCTACTC], 1R [AGGTTAGCTGAGCCACCCAG]; PCR II: 2F [CTCATAGCCGCCTACTCC], 2R [CTAGAACAGGGCAAGCTGGA]) on human multiple tissue cDNA (Clontech, Heidelberg, Germany) or adipocyte mRNA [<xref ref-type="bibr" rid="B42">42</xref>]. Omniscript RT Kit (QIAGEN, Hilden, Germany) was used for reverse transcription. PCR products were cloned into pCR2.1-TOPO (Invitrogen, Karlsruhe, Germany). Sequencing of recombinant clones, sequence assembly, trace file inspection and alignment to genomic sequence was done as described above.</p></sec><sec><title>Mutation screen</title><p>A mutation screen was performed in the 8 coding exons of human <italic>DGAT2 </italic>and also in the predicted promoter region and a non-coding 5' exon. For PCR amplification, primers corresponding to intron sequences were used in order to detect potential splice site variants [for PCR primers see additional file <xref ref-type="supplementary-material" rid="S2">2</xref>]. Mutation screens of exon 6 and 8 were performed using denaturing high performance liquid chromatography (dHPLC) analysis on a Transgenomic WAVE<sup>&#x000ae; </sup>system [Transgenomic, Cheshire, UK; <xref ref-type="bibr" rid="B43">43</xref>]. The optimal melting temperatures for separation of homo- and heteroduplices were deduced from the melting temperature of the PCR-amplicon using WAVEmaker software, version 4.0 (Transgenomic, Cheshire, UK). All chromatograms were compared with chromatograms of sequenced wild-type samples. PCR amplicons showing a peak appearance different to the wild-type pattern were sequenced (SeqLab, G&#x000f6;ttingen, Germany). To detect mutations in exons 1&#x02013;5, 7, the promoter region and the non-coding 5' exon standard nonisotopic single-strand conformation polymorphism analyses (SSCP) was performed [<xref ref-type="bibr" rid="B44">44</xref>]. 15% acrylamide gels (Q-BIOgene, Heidelberg, Germany; 37.5:1) were run at 600 V for 16 h at 4&#x000b0;C and for 5.5 h at ambient temperature; all gels were silver stained. The sensitivity of dHPLC has been described to be approximately 95% [<xref ref-type="bibr" rid="B45">45</xref>] and that of SSCP about 97% when using two temperatures [<xref ref-type="bibr" rid="B46">46</xref>]. All SSCP patterns were compared with patterns of sequenced wild-type samples. Samples that showed a pattern different from that of the wild-types were re-sequenced (Seq Lab, G&#x000f6;ttingen, Germany). The nomenclature of the described variants follows den Dunnen and Antonarakis [<xref ref-type="bibr" rid="B47">47</xref>] and NM_032564.</p></sec><sec><title>Genotyping</title><p>High-throughput genotyping for two additional intronic SNPs (rs1017713, rs3060,) as well as for variants -9447A &#x0003e; G and -140C &#x0003e; T entering the family based association studies was performed as described earlier [<xref ref-type="bibr" rid="B48">48</xref>] using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). For case control association studies, genotyping of SNPs -9447A &#x0003e; G and c.920T &#x0003e; C was perfomed via tetra-ARMS-PCR [<xref ref-type="bibr" rid="B49">49</xref>] [see additional file <xref ref-type="supplementary-material" rid="S3">3</xref>]. For all other SNPs [see additional file <xref ref-type="supplementary-material" rid="S3">3</xref>], PCR with subsequent diagnostic restriction fragment length polymorphism analyses (RFLP) was used. PCR products were run on ethidium bromide-stained 2.5% agarose gels. Positive controls for the variant alleles and a negative control (water) were run on each gel. To validate the genotypes, allele determinations were rated independently by at least two experienced individuals. Discrepancies were resolved unambiguously either by reaching consensus or by retyping. Missings were retyped twice. Genotyping success rate was above 99%. Genotyping of rs3841596, a biallelic trinucleotide repeat was carried out using fluorescence-based semi-automated technique on an automated DNA sequencing machine (LiCor 4200-2; MWG-Biotech, Ebersberg, FRG). Analyses and assignment of the marker alleles were done with ONE-Dscan Version 1.3 software (MWG-Biotech).</p></sec><sec><title>In silico evaluation of non-synonymous variants</title><p>To gain information about putative functional relevance of an amino acid substitution, public sequence database [<xref ref-type="bibr" rid="B34">34</xref>] was mined for full length mammalian and more distant related DGAT2 orthologs where particular attention was given to species surpassing oil production. These data were utilized to determine the evolutionary conservation of the DGAT2 amino acid sequence. Protein sequence alignment was carried out via Omiga (Oxford Molecular Ltd.). Transmembrane domains were predicted <italic>in silico </italic>[<xref ref-type="bibr" rid="B50">50</xref>].</p></sec><sec><title>Statistics</title><p>Associations in the case control sample were analyzed by Cochran-Armitage trend test for genotype frequencies and Fisher's exact test for alleles. Family based association analyses were performed using the pedigree transmission disequilibrium test [PDT; <xref ref-type="bibr" rid="B51">51</xref>]. Analyses of linkage disequilibrium (LD) between the investigated polymorphisms as well as haplotype associations in the families were investigated by FAMHAP v16 [e.g. <xref ref-type="bibr" rid="B52">52</xref>]. All reported p-values are nominal. Due to lack of p-values &#x0003c; 0.05 (see below), adjustment for multiple testing was considered unnecessary.</p></sec></sec><sec><title>Abbreviations</title><p>BMI: body mass index</p><p>CNS: central nervous system</p><p>CNTF: ciliary neurotrophic factor</p><p>DGAT: diacylglycerol O-acyltransferase homolog</p><p>EST: expressed sequence tag</p><p>GAD2: glutamate decarboxylase 2</p><p>GAL: galanin</p><p>MAF: minor allele frequency</p><p>MLB LOD: maximum likelihood binomial logarithm of the odd</p><p>QTL: quantitative trait locus</p><p>SLC6A14: solute carrier family 6 member 14</p><p>SNP: single nucleotide polymorphism</p><p>TM: transmembrane domain</p><p>UCP: uncoupling protein</p><p>UTR: untranslated region</p></sec><sec><title>Authors' contributions</title><p>SF designed and carried out PCR and mutation screening, performed genotyping and drafted the manuscript. KR and MP performedpromoter prediction, evaluation of gene structure and resequencing. AS performed statistical analyses. HBr and HBi performed in silico evaluation of non-synonymous variants. AKW and RF participated in the study design and helped drafting the manuscript. KK and TM performed the high-throughput genotyping. MW contributed mRNA for sequencing analyses and participated in the study design. AH and JH conceived the study, and participated in its design and coordination and drafted the manuscript. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional File 1</title><p>mRNAs transcribed from human <italic>DGAT2 </italic>locus. list of mRNAs transcribed from human DGAT2 locus, including status, evidence and gene structure defined by mRNA</p></caption><media xlink:href="1471-2156-8-17-S1.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional File 2</title><p>PCR primer for mutation screen in <italic>DGAT2</italic>. list of PCR primer for mutation screen in DGAT2 exons</p></caption><media xlink:href="1471-2156-8-17-S2.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional File 3</title><p>Genotyping information: Genotypes were generated via RFLP, tetra-arms PCR [<xref ref-type="bibr" rid="B3">3</xref>] and MALDI-TOF. Genotyping information for investigated SNPs including primer, genotyping methods and restriction enzymes</p></caption><media xlink:href="1471-2156-8-17-S3.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>The participation of the probands and their families is gratefully acknowledged. This project was supported by the Deutsche Forschungsgemeinschaft, Germany (DFG) grant HE 1446/4-1, the European Union (Framework VI; LSHM-CT2003-503041), and the National Genome Research Net (NGFN2) "Obesity and Related Disorders".</p></sec></ack><ref-list><ref id="B1"><citation citation-type="other"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity</article-title><source>Geneva</source><year>1998</year></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>HH</given-names></name><name><surname>Neale</surname><given-names>MC</given-names></name><name><surname>Eaves</surname><given-names>LJ</given-names></name></person-group><article-title>Genetic and environmental factors in relative body weight and human adiposity</article-title><source>Behav Genet</source><year>1997</year><volume>27</volume><fpage>325</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">9519560</pub-id><pub-id pub-id-type="doi">10.1023/A:1025635913927</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suviolahti</surname><given-names>E</given-names></name><name><surname>Oksanen</surname><given-names>LJ</given-names></name><name><surname>Ohman</surname><given-names>M</given-names></name><name><surname>Cantor</surname><given-names>RM</given-names></name><name><surname>Ridderstrale</surname><given-names>M</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Rissanen</surname><given-names>A</given-names></name><name><surname>Mustajoki</surname><given-names>P</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Vartiainen</surname><given-names>E</given-names></name><name><surname>Silander</surname><given-names>K</given-names></name><name><surname>Kilpikari</surname><given-names>R</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>Kontula</surname><given-names>K</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Pajukanta</surname><given-names>P</given-names></name></person-group><article-title>The SLC6A14 gene shows evidence of association with obesity</article-title><source>J Clin Invest</source><year>2003</year><volume>112</volume><fpage>1762</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">14660752</pub-id><pub-id pub-id-type="doi">10.1172/JCI200317491</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>E</given-names></name><name><surname>Boutin</surname><given-names>P</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Charles</surname><given-names>MA</given-names></name><name><surname>Clement</surname><given-names>K</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name></person-group><article-title>Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>2483</fpage><lpage>6</lpage><comment>Erratum in: Diabetes 2005; <bold>54</bold>: 587</comment><pub-id pub-id-type="pmid">15331564</pub-id><pub-id pub-id-type="doi">10.2337/diabetes.53.9.2483</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boutin</surname><given-names>P</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Vasseur</surname><given-names>F</given-names></name><name><surname>Dubois</surname><given-names>S</given-names></name><name><surname>Corset</surname><given-names>L</given-names></name><name><surname>Seron</surname><given-names>K</given-names></name><name><surname>Bekris</surname><given-names>L</given-names></name><name><surname>Cabellon</surname><given-names>J</given-names></name><name><surname>Neve</surname><given-names>B</given-names></name><name><surname>Vasseur-Delannoy</surname><given-names>V</given-names></name><name><surname>Chikri</surname><given-names>M</given-names></name><name><surname>Charles</surname><given-names>MA</given-names></name><name><surname>Clement</surname><given-names>K</given-names></name><name><surname>Lernmark</surname><given-names>A</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name></person-group><article-title>GAD2 on chromosome 10p12 is a candidate gene for human obesity</article-title><source>PLoS Biol</source><year>2003</year><volume>1</volume><fpage>E68</fpage><pub-id pub-id-type="pmid">14691540</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0000068</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Boutin</surname><given-names>P</given-names></name><name><surname>Tounian</surname><given-names>A</given-names></name><name><surname>Deweirder</surname><given-names>M</given-names></name><name><surname>Aout</surname><given-names>M</given-names></name><name><surname>Jouret</surname><given-names>B</given-names></name><name><surname>Heude</surname><given-names>B</given-names></name><name><surname>Weill</surname><given-names>J</given-names></name><name><surname>Tauber</surname><given-names>M</given-names></name><name><surname>Tounian</surname><given-names>P</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name></person-group><article-title>Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children?</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><fpage>2384</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">15671113</pub-id><pub-id pub-id-type="doi">10.1210/jc.2004-1468</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swarbrick</surname><given-names>MM</given-names></name><name><surname>Waldenmaier</surname><given-names>B</given-names></name><name><surname>Pennacchio</surname><given-names>LA</given-names></name><name><surname>Lind</surname><given-names>DL</given-names></name><name><surname>Cavazos</surname><given-names>MM</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Merriman</surname><given-names>R</given-names></name><name><surname>Ustaszewska</surname><given-names>A</given-names></name><name><surname>Malloy</surname><given-names>M</given-names></name><name><surname>Scherag</surname><given-names>A</given-names></name><name><surname>Hsueh</surname><given-names>WC</given-names></name><name><surname>Rief</surname><given-names>W</given-names></name><name><surname>Mauvais-Jarvis</surname><given-names>F</given-names></name><name><surname>Pullinger</surname><given-names>CR</given-names></name><name><surname>Kane</surname><given-names>JP</given-names></name><name><surname>Dent</surname><given-names>R</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Kwok</surname><given-names>PY</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Vaisse</surname><given-names>C</given-names></name></person-group><article-title>Lack of support for the association between GAD2 polymorphisms and severe human obesity</article-title><source>PLoS Biol</source><year>2005</year><volume>3</volume><fpage>e315</fpage><pub-id pub-id-type="pmid">16122350</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0030315</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saar</surname><given-names>K</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Ruschendorf</surname><given-names>F</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name><name><surname>Friedel</surname><given-names>S</given-names></name><name><surname>Schauble</surname><given-names>N</given-names></name><name><surname>Nurnberg</surname><given-names>P</given-names></name><name><surname>Siegfried</surname><given-names>W</given-names></name><name><surname>Goldschmidt</surname><given-names>HP</given-names></name><name><surname>Schafer</surname><given-names>H</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>Genome scan for childhood and adolescent obesity in German families</article-title><source>Pediatrics</source><year>2003</year><volume>111</volume><fpage>321</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12563058</pub-id><pub-id pub-id-type="doi">10.1542/peds.111.2.321</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>RA</given-names></name><name><surname>Thompson</surname><given-names>DB</given-names></name><name><surname>Foroud</surname><given-names>T</given-names></name><name><surname>Garvey</surname><given-names>WT</given-names></name><name><surname>Bennett</surname><given-names>PH</given-names></name><name><surname>Bogardus</surname><given-names>C</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name></person-group><article-title>Genomewide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. Pima Diabetes Gene Group</article-title><source>Am J Hum Genet</source><year>1997</year><volume>60</volume><fpage>166</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">8981960</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pratley</surname><given-names>RE</given-names></name><name><surname>Thompson</surname><given-names>DB</given-names></name><name><surname>Prochazka</surname><given-names>M</given-names></name><name><surname>Baier</surname><given-names>L</given-names></name><name><surname>Mott</surname><given-names>D</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name><name><surname>Sakul</surname><given-names>H</given-names></name><name><surname>Ehm</surname><given-names>MG</given-names></name><name><surname>Burns</surname><given-names>DK</given-names></name><name><surname>Foroud</surname><given-names>T</given-names></name><name><surname>Garvey</surname><given-names>WT</given-names></name><name><surname>Hanson</surname><given-names>RL</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Bennett</surname><given-names>PH</given-names></name><name><surname>Bogardus</surname><given-names>C</given-names></name></person-group><article-title>An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians</article-title><source>J Clin Invest</source><year>1998</year><volume>101</volume><fpage>1757</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">9541507</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>RM</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Valle</surname><given-names>TT</given-names></name><name><surname>Hauser</surname><given-names>ER</given-names></name><name><surname>Magnuson</surname><given-names>VL</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Silander</surname><given-names>K</given-names></name><name><surname>Ally</surname><given-names>DS</given-names></name><name><surname>Chines</surname><given-names>P</given-names></name><name><surname>Blaschak-Harvan</surname><given-names>J</given-names></name><name><surname>Douglas</surname><given-names>JA</given-names></name><name><surname>Duren</surname><given-names>WL</given-names></name><name><surname>Epstein</surname><given-names>MP</given-names></name><name><surname>Fingerlin</surname><given-names>TE</given-names></name><name><surname>Kaleta</surname><given-names>HS</given-names></name><name><surname>Lange</surname><given-names>EM</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>McEachin</surname><given-names>RC</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Trager</surname><given-names>E</given-names></name><name><surname>White</surname><given-names>PP</given-names></name><name><surname>Balow</surname><given-names>J</given-names><suffix>Jr</suffix></name><name><surname>Birznieks</surname><given-names>G</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Eldridge</surname><given-names>W</given-names></name></person-group><article-title>The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><fpage>1186</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">11032784</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Kirby</surname><given-names>A</given-names></name><name><surname>Schaffner</surname><given-names>SF</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Parker</surname><given-names>A</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name><name><surname>Platko</surname><given-names>J</given-names></name><name><surname>Gaudet</surname><given-names>D</given-names></name><name><surname>Hudson</surname><given-names>TJ</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name></person-group><article-title>Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height</article-title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>106</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">11410839</pub-id><pub-id pub-id-type="doi">10.1086/321287</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almind</surname><given-names>K</given-names></name><name><surname>Kulkarni</surname><given-names>RN</given-names></name><name><surname>Lannon</surname><given-names>SM</given-names></name><name><surname>Kahn</surname><given-names>CR</given-names></name></person-group><article-title>Identification of interactive loci linked to insulin and leptin in mice with genetic insulin resistance</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>1535</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">12765967</pub-id><pub-id pub-id-type="doi">10.2337/diabetes.52.6.1535</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>WK</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Chua</surname><given-names>M</given-names></name><name><surname>Kershaw</surname><given-names>E</given-names></name><name><surname>Power-Kehoe</surname><given-names>L</given-names></name><name><surname>Tsuji</surname><given-names>M</given-names></name><name><surname>Wu-Peng</surname><given-names>XS</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Chua</surname><given-names>SC</given-names><suffix>Jr</suffix></name><name><surname>Leibel</surname><given-names>RL</given-names></name></person-group><article-title>Genetic modifiers of Leprfa associated with variability in insulin production and susceptibility to NIDDM</article-title><source>Genomics</source><year>1997</year><volume>41</volume><fpage>332</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">9169130</pub-id><pub-id pub-id-type="doi">10.1006/geno.1997.4672</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munzberg</surname><given-names>H</given-names></name><name><surname>Tafel</surname><given-names>J</given-names></name><name><surname>Busing</surname><given-names>B</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Mayer</surname><given-names>H</given-names></name><name><surname>Siegfried</surname><given-names>W</given-names></name><name><surname>Matthaei</surname><given-names>S</given-names></name><name><surname>Greten</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Hamann</surname><given-names>A</given-names></name></person-group><article-title>Screening for variability in the ciliary neurotrophic factor (CNTF) gene: no evidence for association with human obesity</article-title><source>Exp Clin Endocrinol Diabetes</source><year>1998</year><volume>106</volume><fpage>108</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">9628240</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schauble</surname><given-names>N</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Siegfried</surname><given-names>W</given-names></name><name><surname>Goldschmidt</surname><given-names>H</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>No evidence for involvement of the promoter polymorphism -866 G/A of the UCP2 gene in childhood-onset obesity in humans</article-title><source>Exp Clin Endocrinol Diabetes</source><year>2003</year><volume>111</volume><fpage>73</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12746756</pub-id><pub-id pub-id-type="doi">10.1055/s-2003-39232</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schauble</surname><given-names>N</given-names></name><name><surname>Reichwald</surname><given-names>K</given-names></name><name><surname>Grassl</surname><given-names>W</given-names></name><name><surname>Bechstein</surname><given-names>H</given-names></name><name><surname>Muller</surname><given-names>HC</given-names></name><name><surname>Scherag</surname><given-names>A</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Utting</surname><given-names>M</given-names></name><name><surname>Siegfried</surname><given-names>W</given-names></name><name><surname>Goldschmidt</surname><given-names>H</given-names></name><name><surname>Blundell</surname><given-names>J</given-names></name><name><surname>Lawton</surname><given-names>C</given-names></name><name><surname>Alam</surname><given-names>R</given-names></name><name><surname>Whybrow</surname><given-names>S</given-names></name><name><surname>Stubbs</surname><given-names>J</given-names></name><name><surname>Platzer</surname><given-names>M</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name></person-group><article-title>Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity</article-title><source>J Nutr</source><year>2005</year><volume>135</volume><fpage>1387</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">15930442</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cases</surname><given-names>S</given-names></name><name><surname>Stone</surname><given-names>SJ</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Yen</surname><given-names>E</given-names></name><name><surname>Tow</surname><given-names>B</given-names></name><name><surname>Lardizabal</surname><given-names>KD</given-names></name><name><surname>Voelker</surname><given-names>T</given-names></name><name><surname>Farese</surname><given-names>RV</given-names><suffix>Jr</suffix></name></person-group><article-title>Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>38870</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11481335</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M106219200</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lardizabal</surname><given-names>KD</given-names></name><name><surname>Mai</surname><given-names>JT</given-names></name><name><surname>Wagner</surname><given-names>NW</given-names></name><name><surname>Wyrick</surname><given-names>A</given-names></name><name><surname>Voelker</surname><given-names>T</given-names></name><name><surname>Hawkins</surname><given-names>DJ</given-names></name></person-group><article-title>DGAT2 is a new diacylglycerol acyltransferase gene family: purification, cloning, and expression in insect cells of two polypeptides from Mortierella ramanniana with diacylglycerol acyltransferase activity</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>38862</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11481333</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M106168200</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>R</given-names></name><name><surname>Tobe</surname><given-names>K</given-names></name><name><surname>Aoyama</surname><given-names>M</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Ohsugi</surname><given-names>M</given-names></name><name><surname>Kamei</surname><given-names>N</given-names></name><name><surname>Nemoto</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Yamauchi</surname><given-names>T</given-names></name><name><surname>Kubota</surname><given-names>N</given-names></name><name><surname>Terauchi</surname><given-names>Y</given-names></name><name><surname>Kadowaki</surname><given-names>T</given-names></name></person-group><article-title>Expression of DGAT2 in white adipose tissue is regulated by central leptin action</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>3331</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15550388</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M410955200</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SJ</given-names></name><name><surname>Cases</surname><given-names>S</given-names></name><name><surname>Jensen</surname><given-names>DR</given-names></name><name><surname>Chen</surname><given-names>HC</given-names></name><name><surname>Sande</surname><given-names>E</given-names></name><name><surname>Tow</surname><given-names>B</given-names></name><name><surname>Sanan</surname><given-names>DA</given-names></name><name><surname>Raber</surname><given-names>J</given-names></name><name><surname>Eckel</surname><given-names>RH</given-names></name><name><surname>Farese</surname><given-names>RV</given-names><suffix>Jr</suffix></name></person-group><article-title>Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">10802663</pub-id><pub-id pub-id-type="doi">10.1038/75651</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>SJ</given-names></name><name><surname>Myers</surname><given-names>HM</given-names></name><name><surname>Watkins</surname><given-names>SM</given-names></name><name><surname>Brown</surname><given-names>BE</given-names></name><name><surname>Feingold</surname><given-names>KR</given-names></name><name><surname>Elias</surname><given-names>PM</given-names></name><name><surname>Farese</surname><given-names>RV</given-names><suffix>Jr</suffix></name></person-group><article-title>Lipopenia and skin barrier abnormalities in DGAT2-deficient mice</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>11767</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">14668353</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M311000200</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cordell</surname><given-names>HJ</given-names></name></person-group><article-title>Sample size requirements to control for stochastic variation in magnitude and location of allele-sharing linkage statistics in affected sibling pairs</article-title><source>Ann Hum Genet</source><year>2001</year><volume>65</volume><fpage>491</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">11806857</pub-id><pub-id pub-id-type="doi">10.1046/j.1469-1809.2001.6550491.x</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Partridge</surname><given-names/></name><name><surname>Liu</surname><given-names/></name><name><surname>Kim</surname><given-names/></name><name><surname>Bowie</surname><given-names/></name></person-group><article-title>Transmembrane domain helix packing stabilizes integrin alphaIIbbeta3 in the low affinity state</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>7294</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">15591321</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M412701200</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biebermann</surname><given-names>H</given-names></name><name><surname>Ambrugger</surname><given-names>P</given-names></name><name><surname>Tarnow</surname><given-names>P</given-names></name><name><surname>von Moers</surname><given-names>A</given-names></name><name><surname>Schweizer</surname><given-names>U</given-names></name><name><surname>Grueters</surname><given-names>A</given-names></name></person-group><article-title>Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8</article-title><source>Eur J Endocrinol</source><year>2005</year><volume>153</volume><fpage>359</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">16131597</pub-id><pub-id pub-id-type="doi">10.1530/eje.1.01980</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gromoll</surname><given-names>J</given-names></name><name><surname>Partsch</surname><given-names>CJ</given-names></name><name><surname>Simoni</surname><given-names>M</given-names></name><name><surname>Nordhoff</surname><given-names>V</given-names></name><name><surname>Sippell</surname><given-names>WG</given-names></name><name><surname>Nieschlag</surname><given-names>E</given-names></name><name><surname>Saxena</surname><given-names>BB</given-names></name></person-group><article-title>A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty</article-title><source>J Clin Endocrinol Metab</source><year>1998</year><volume>83</volume><fpage>476</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">9467560</pub-id><pub-id pub-id-type="doi">10.1210/jc.83.2.476</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ladias</surname><given-names>JA</given-names></name><name><surname>Karathanasis</surname><given-names>SK</given-names></name></person-group><article-title>Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily</article-title><source>Science</source><volume>251</volume><fpage>561</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">1899293</pub-id><pub-id pub-id-type="doi">10.1126/science.1899293</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torra</surname><given-names>IP</given-names></name><name><surname>Chinetti</surname><given-names>G</given-names></name><name><surname>Duval</surname><given-names>C</given-names></name><name><surname>Fruchart</surname><given-names>JC</given-names></name><name><surname>Staels</surname><given-names>B</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice</article-title><source>Curr Opin Lipidol</source><year>2001</year><volume>12</volume><fpage>245</fpage><lpage>54</lpage><comment>Review</comment><pub-id pub-id-type="pmid">11353326</pub-id><pub-id pub-id-type="doi">10.1097/00041433-200106000-00002</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Lentes</surname><given-names>KU</given-names></name><name><surname>Rosenkranz</surname><given-names>K</given-names></name><name><surname>Barth</surname><given-names>N</given-names></name><name><surname>Roth</surname><given-names>H</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Hennighausen</surname><given-names>K</given-names></name><name><surname>Coners</surname><given-names>H</given-names></name><name><surname>Wurmser</surname><given-names>H</given-names></name><name><surname>Jacob</surname><given-names>K</given-names></name><name><surname>Romer</surname><given-names>G</given-names></name><name><surname>Winnikes</surname><given-names>U</given-names></name><name><surname>Mayer</surname><given-names>H</given-names></name><name><surname>Herzog</surname><given-names>W</given-names></name><name><surname>Lehmkuhl</surname><given-names>G</given-names></name><name><surname>Poustka</surname><given-names>F</given-names></name><name><surname>Schmidt</surname><given-names>MH</given-names></name><name><surname>Blum</surname><given-names>WF</given-names></name><name><surname>Pirke</surname><given-names>KM</given-names></name><name><surname>Schafer</surname><given-names>H</given-names></name><name><surname>Grzeschik</surname><given-names>KH</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>Beta 3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa</article-title><source>Int J Obes Relat Metab Disord</source><year>1997</year><volume>21</volume><fpage>224</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">9080262</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0800391</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Himmelmann</surname><given-names>GW</given-names></name><name><surname>Heseker</surname><given-names>H</given-names></name><name><surname>Schafer</surname><given-names>H</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name></person-group><article-title>Use of percentiles for the body mass index in anorexia nervosa: diagnostic, epidemiological, and therapeutic considerations</article-title><source>Int J Eat Disord</source><year>1996</year><volume>19</volume><fpage>359</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">9156689</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1098-108X(199605)19:4&#x0003c;359::AID-EAT4&#x0003e;3.0.CO;2-K</pub-id></citation></ref><ref id="B31"><citation citation-type="other"><article-title>Genomatix</article-title><ext-link ext-link-type="uri" xlink:href="http://www.genomatix.de"/></citation></ref><ref id="B32"><citation citation-type="other"><article-title>UCSC Genome Bioinformatics</article-title><ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/"/></citation></ref><ref id="B33"><citation citation-type="other"><article-title>ENSEMBL genome browser</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org"/></citation></ref><ref id="B34"><citation citation-type="other"><article-title>The National Centre for Biotechnology Information (NCBI)</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov"/></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonfield</surname><given-names>JK</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Staden</surname><given-names>R</given-names></name></person-group><article-title>A new DNA sequence assembly program</article-title><source>Nucleic Acids Res</source><year>1995</year><volume>23</volume><fpage>4992</fpage><lpage>4999</lpage><pub-id pub-id-type="pmid">8559656</pub-id><pub-id pub-id-type="doi">10.1093/nar/23.24.4992</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Florea</surname><given-names>L</given-names></name><name><surname>Hartzell</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name></person-group><article-title>A computer program for aligning a cDNA sequence with a genomic DNA sequence</article-title><source>Genome Res</source><year>1998</year><volume>8</volume><fpage>967</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">9750195</pub-id></citation></ref><ref id="B37"><citation citation-type="other"><article-title>RZPD German Resource Center for Genome Research (RZPD)</article-title><ext-link ext-link-type="uri" xlink:href="http://www.rzpd.de/"/></citation></ref><ref id="B38"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Fritsch</surname><given-names>EF</given-names></name><name><surname>Maniatis</surname><given-names>T</given-names></name></person-group><source>Molecular Cloning, A Laboratory Manual</source><year>1989</year><edition>2</edition><publisher-name>Cold Spring Harbor (N.Y.) Laboratory Press</publisher-name></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ewing</surname><given-names>B</given-names></name><name><surname>Hillier</surname><given-names>L</given-names></name><name><surname>Wendl</surname><given-names>MC</given-names></name><name><surname>Green</surname><given-names>P</given-names></name></person-group><article-title>Base-calling of automated sequencer traces using phred. I. Accuracy assessment</article-title><source>Genome Res</source><year>1998</year><volume>8</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">9521921</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ewing</surname><given-names>B</given-names></name><name><surname>Green</surname><given-names>P</given-names></name></person-group><article-title>Base-calling of automated sequencer traces using phred. II. Error probabilities</article-title><source>Genome Res</source><year>1998</year><volume>8</volume><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">9521922</pub-id></citation></ref><ref id="B41"><citation citation-type="other"><article-title>Phragment assembly program (phrap)</article-title><ext-link ext-link-type="uri" xlink:href="http://www.phrap.org/phrap.docs/phrap.html"/></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wabitsch</surname><given-names>M</given-names></name><name><surname>Brenner</surname><given-names>RE</given-names></name><name><surname>Melzner</surname><given-names>I</given-names></name><name><surname>Braun</surname><given-names>M</given-names></name><name><surname>Moller</surname><given-names>P</given-names></name><name><surname>Heinze</surname><given-names>E</given-names></name><name><surname>Debatin</surname><given-names>KM</given-names></name><name><surname>Hauner</surname><given-names>H</given-names></name></person-group><article-title>Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation</article-title><source>Int J Obes Relat Metab Disord</source><year>2001</year><volume>25</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">11244452</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0801520</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oefner</surname><given-names>PJ</given-names></name><name><surname>Underhill</surname><given-names>PA</given-names></name></person-group><article-title>DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC)</article-title><source>Curr Prot Hum Genet</source><year>1998</year><volume>7</volume><fpage>1</fpage><lpage>10</lpage></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Nottebom</surname><given-names>K</given-names></name><name><surname>Heibult</surname><given-names>O</given-names></name><name><surname>Becker</surname><given-names>I</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Gerber</surname><given-names>G</given-names></name><name><surname>Sina</surname><given-names>M</given-names></name><name><surname>Gorg</surname><given-names>T</given-names></name><name><surname>Mayer</surname><given-names>H</given-names></name><name><surname>Siegfried</surname><given-names>W</given-names></name><name><surname>Fichter</surname><given-names>M</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans</article-title><source>J Clin Endocrinol Metab</source><year>1999</year><volume>84</volume><fpage>1483</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10199800</pub-id><pub-id pub-id-type="doi">10.1210/jc.84.4.1483</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>LA</given-names></name><name><surname>Taylor</surname><given-names>CF</given-names></name><name><surname>Taylor</surname><given-names>GR</given-names></name></person-group><article-title>A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning</article-title><source>Hum Mutat</source><year>2000</year><volume>15</volume><fpage>556</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">10862085</pub-id><pub-id pub-id-type="doi">10.1002/1098-1004(200006)15:6&#x0003c;556::AID-HUMU7&#x0003e;3.0.CO;2-C</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salazar</surname><given-names>LA</given-names></name><name><surname>Hirata</surname><given-names>MH</given-names></name><name><surname>Hirata</surname><given-names>RD</given-names></name></person-group><article-title>Increasing the sensitivity of single-strand conformation polymorphism analysis of the LDLR gene mutations in brazilian patients with familial hypercholesterolemia</article-title><source>Clin Chem Lab Med</source><year>2002</year><volume>40</volume><fpage>441</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12113284</pub-id><pub-id pub-id-type="doi">10.1515/CCLM.2002.075</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>den Dunnen</surname><given-names>JT</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name></person-group><article-title>Nomenclature for the description of human sequence variations</article-title><source>Hum Genet</source><year>2001</year><volume>109</volume><fpage>121</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">11479744</pub-id><pub-id pub-id-type="doi">10.1007/s004390100505</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HJ</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Dempfle</surname><given-names>A</given-names></name><name><surname>Schauble</surname><given-names>N</given-names></name><name><surname>Friedel</surname><given-names>S</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Fontenla-Horro</surname><given-names>F</given-names></name><name><surname>Wudy</surname><given-names>S</given-names></name><name><surname>Hagemann</surname><given-names>S</given-names></name><name><surname>Gortner</surname><given-names>L</given-names></name><name><surname>Huse</surname><given-names>K</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Bettecken</surname><given-names>T</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Schafer</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name></person-group><article-title>Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>157</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">14715843</pub-id><pub-id pub-id-type="doi">10.1210/jc.2003-031395</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Dhillon</surname><given-names>S</given-names></name><name><surname>Ke</surname><given-names>X</given-names></name><name><surname>Collins</surname><given-names>AR</given-names></name><name><surname>Day</surname><given-names>IN</given-names></name></person-group><article-title>An efficient procedure for genotyping single ucleotide polymorphisms</article-title><source>Nucleic Acids Res</source><year>2001</year><volume>29</volume><fpage>E88</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11522844</pub-id><pub-id pub-id-type="doi">10.1093/nar/29.17.e88</pub-id></citation></ref><ref id="B50"><citation citation-type="other"><article-title>TMHMM</article-title><ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/TMHMM/"/></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>ER</given-names></name><name><surname>Monks</surname><given-names>SA</given-names></name><name><surname>Warren</surname><given-names>LL</given-names></name><name><surname>Kaplan</surname><given-names>NL</given-names></name></person-group><article-title>A test for linkage and association in general pedigrees: the pedigree disequilibrium test</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><fpage>146</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">10825280</pub-id><pub-id pub-id-type="doi">10.1086/302957</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>T</given-names></name><name><surname>Knapp</surname><given-names>M</given-names></name></person-group><article-title>A powerful strategy to account for multiple testing in the context of haplotype analysis</article-title><source>Am J Hum Genet</source><year>2004</year><volume>75</volume><fpage>561</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">15290652</pub-id><pub-id pub-id-type="doi">10.1086/424390</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Himmelmann</surname><given-names>GW</given-names></name><name><surname>Heseker</surname><given-names>H</given-names></name><name><surname>Schafer</surname><given-names>H</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name></person-group><article-title>Use of percentiles for the body mass index in anorexia nervosa: diagnostic, epidemiological, and therapeutic considerations</article-title><source>Int J Eat Disord</source><year>1996</year><volume>19</volume><fpage>359</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">9156689</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1098-108X(199605)19:4&#x0003c;359::AID-EAT4&#x0003e;3.0.CO;2-K</pub-id></citation></ref></ref-list></back></article> 